Abstract: A device and a method for delivering a solution to tissues and/or organs. The solution contains at least one solvent and at least one solute. The device includes at least one chamber which contains sodium 2-mercaptoethanesulfonate in powder form. The method includes the steps of dissolving the solute in the solvent inside the device. The resulting solution is delivered immediately to tissues and/or organs to facilitate dissection.
Abstract: A sterile lyophilizate composition having improved stability and shelf-life. The lyophilizate includes from 30 to 100% of Mesna and 0 to 70% of an excipient. A process for the preparation of the sterile lyophilizate composition and a dosage unit formulation including the lyophilizate composition.
Abstract: The invention provides a sterile lyophilizate composition having improved stability and shelf-life, the lyophilizate having from 30 to 100% of Mesna and 0 to 70% of an excipient. The invention further provides a process for the preparation of the sterile lyophilizate composition and a dosage unit formulation with the lyophilizate composition.
Abstract: A device and a method for delivering a solution to tissues and/or organs is described. The solution contains at least one solvent and at least one solute. The device includes at least one chamber which contains sodium 2-mercaptoethanesulfonate in powder form. The method includes the steps of dissolving the solute in the solvent inside the device. The resulting solution is delivered immediately to tissues and/or organs to facilitate dissection.